Knome turns to China for genome sequencing

Knome turns to China for genome sequencing

(UPDATED: See below.)

Knome, the Cambridge, Mass., startup that will sequence the entire genomes of 20 customers for $350,000 apiece, launched its business back in November without ever explaining exactly how it planned to carry out the heavy lifting of whole-genome sequencing. At the time, CEO and co-founder Jorge Conde said only that unspecified “partners” would be helping out Knome with the actual work of reading out and analyzing six billion “letters” of DNA for each customer.

Yesterday,… Continue Reading

The nitty-gritty on Knome: How it works

The nitty-gritty on Knome: How it works

(UPDATED: See below.)

(NOTE: This is the second of two posts on Knome, a newly launched startup that offers to sequence your entire genome for $350,000. For part one, which provides a broad overview of Knome’s whole-genome sequencing and how it differs from services offered by other personal-genomics companies, click here.)

First things first: The company’s name is pronounced “nome,” as in the Alaskan city. A bemused debate over proper pronunciation has circulated among folks in and around the… Continue Reading

Got $350,000? Knome will provide your full genome

Got $350,000? Knome will provide your full genome

In a surprising move, Knome, a Boston-area startup, is offering whole-genome sequencing to individuals.

This is big, because Knome’s mapping of your genome is the full deal, not the rough draft offered by competitors such as 23andMe. (Full details here.) For the moment, a lot of this is gee-whiz stuff, and maybe even a status symbol of sorts, since Knome can only handle 20 individuals who are willing and able to cough up $350,000 for the… Continue Reading

Genomics for the rich: Knome reads your entire genetic code — for the low, low price of $350,000

Genomics for the rich: Knome reads your entire genetic code — for the low, low price of $350,000

(UPDATED: See below.)

(NOTE: This is the first of two posts taking a close look at Knome. For part two, which examines Knome’s business model and how its service works — based largely on an interview with Knome CEO Jorge Conde — see here.)

First it was genomic pioneers James Watson and Craig Venter. Next up are the first ten volunteers in Harvard geneticist George Church’s Personal Genome Project. And now just about anyone can have their entire genome… Continue Reading